| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technical Officer | VP, Pharmaceutical Development
1 company
Cappello Joseph is a Chief Technical Officer at Genelux Corporation. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $453K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | GNLX Genelux Corporation | Chief Technical Officer | Sell | 906 | $2.42 | $2,192.52 | -0.6% | +22.5% | - | |
| Nov 17, 2025 | GNLX Genelux Corp | Chief Technical Officer | Sell | 3,706 | $3.88 | $14,361.21 | -0.8% | -51.2% | - | |
| May 12, 2025 | GNLX Genelux Corp | VP, Pharmaceutical Development | Sell | 4,737 | $2.92 | $13,832.04 | -8.3% | +18.0% | +6.8% | |
| Dec 16, 2024 | GNLX Genelux Corp | VP, Pharmaceutical Development | Sell | 6,300 | $2.34 | $14,742.00 | -30.1% | +58.1% | +73.7% | |
| Aug 18, 2023 | GNLX Genelux Corp | VP, Pharmaceutical Development | Sell | 3,265 | $23.73 | $77,478.45 | -36.3% | -45.3% | -91.6% |